DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr | ₹1,823 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
Year | Operating Profit |
---|---|
Mar2024 | ₹2,206 Cr |
Mar2023 | ₹2,369 Cr |
Mar2022 | ₹3,881 Cr |
Mar2021 | ₹2,861 Cr |
Mar2020 | ₹1,823 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹2,206 Cr | -6.88 | |
Mar2023 | ₹2,369 Cr | -38.96 | |
Mar2022 | ₹3,881 Cr | 35.65 | |
Mar2021 | ₹2,861 Cr | 56.92 | |
Mar2020 | ₹1,823 Cr | - |
Compare Operating Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹180,236.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
MANKIND PHARMA | ₹109,464.0 Cr | 5% | 12% | 27.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.9% |
1.5% |
48.1% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses